Ad
related to: bristol-myers stock- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Trade
Search results
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend...
Benzinga· 7 days agoThese are often companies that have high free cash flows and reward shareholders with a high...
Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
Zacks· 5 days agoFree Report) announced that the European Commission (EC) has approved its blockbuster immuno-oncology drug, Opdivo (nivolumab), in combination with a chemotherapy combination, cisplatin and ...
...Pundits Torn Over Fate Of $76 Trillion In Retirement Funds - CVS Health (NYSE:CVS), Bristol-Myers...
Benzinga· 6 days agoThe mass retirement of the boomer generation has been anticipated as one of the most impactful...
Bristol Myers Squibb checks 'yes' on another Prothena neurodegenerative therapy
FierceBiotech· 6 days agoBristol Myers Squibb is again dipping into the well of therapies being developed by Prothena, this...
7 Underappreciated Stocks With 25% Return Potential in 2024
InvestorPlace· 5 days agoWhether investors refer to them as undervalued or hidden gems, underappreciated stocks are always...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
The Motley Fool via AOL· 5 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 4 days agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 15 hours agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company ...
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
WROC Rochester· 7 days ago(NASDAQ: ONCY) (TSX: ONC), TScan Therapeutics, Inc. (NASDAQ: TCRX), Bristol-Myers Squibb Company...
Market Today: Prothena's Licensing Deal with Bristol Myers and E
Guru Focus· 6 days agoMarket Overview The stock market exhibited mixed action today. There wasn't a lot of conviction from...
Ad
related to: bristol-myers stock
